GRN competitively binds with TNFR1/2 to disrupt TNF-α function, which in turn leads to increased IL-10 production in T regulatory cells in conditions such as rheumatoid arthritis and inflammatory bowel disease [64, 65]. Here, TNFRSF1A is linked to inflammatory bowel disease.